Vontobel Won’t Abandon BB Biotech Bid, SonntagsZeitung Reports

Vontobel Holding AG will persist with its bid to buy BB Biotech AG after an initial offer was rejected, SonntagsZeitung reported, citing Vontobel’s head of corporate finance Hanspeter Gehrer.

BB Biotech shareholders in Switzerland and abroad have encouraged Vontobel to continue pursuing the takeover, the Swiss newspaper quoted Gehrer as saying.